I

Intuitive Surgical

Builds robots for minimally invasive surgery

Business Systems Analyst

Full-TimeUpdated on 10/23/2026
No salary listed
Senior, Expert
Bachelor's
Bengaluru, Karnataka, India
HybridHybrid schedule: 3 days per week in the office; 15% travel.
Business & StrategyBusiness Analysis

About the job

Requirements
  • Experience in a regulatory or quality organization in a medical device company.
  • Experience with and knowledge of the functional and technical aspects of a product lifecycle management (PLM) system; Agile is preferred.
  • Knowledge of change control principles for Document Control and IT systems.
  • Experience working on process and system improvement projects.
  • Working knowledge of Microsoft Office products, including Microsoft Word, Microsoft Excel, and Microsoft Visio.
  • Strong critical and analytical thinking and problem-solving skills.
  • Strong attention to detail.
  • Ability to plan and organize, adapt, and react promptly and efficiently to project adjustments and alterations.
  • Experience working with cross-functional project teams of five or more people.
  • Ability to work hands-on in a team-oriented, collaborative environment.
  • Ability to work in a high-stress, changing environment.
  • Ability to communicate clearly and effectively with business stakeholders and technical team members, including IT.
  • Ability to work with minimal supervision.
  • A university degree and a minimum of 6–10 years of equivalent work experience.
  • Training in Quality System Regulations and ISO requirements.
  • Project Management training.
  • Quality Systems Validation training.
Responsibilities
  • Execute improvement activities for the PLM system (Agile) and Document Control processes.
  • Represent Document Control during project requirements definition.
  • Participate in planning sessions for approved projects and provide input to requirements.
  • Participate in multiple project teams and work with business owners to ensure teams understand users’ business activities and define acceptance criteria.
  • Participate in daily stand-ups, resolve conflicts, and escalate issues as required.
  • Create test scripts for PLM and Document Control projects and execute user acceptance testing.
  • Work with Computer System Validation groups in Regulatory and IT to ensure project compliance with regulatory requirements and company CSV policies and procedures.
  • Identify and resolve project issues and manage project dependencies within the Document Control environment to keep the critical path on track.
  • Update impacted procedures and ensure required documentation is updated and released at project implementation.
  • Support and contribute to the Agile Training Forum, including providing input to slide content about processes and PLM system questions.
  • Review, assess, and implement approval matrix requests, and support approval matrix improvements.
  • Review and assess Document Control tickets, understand issue details and requirements, and resolve complex tickets.
  • Process ECOs and respond to internal customer issues as part of the embedded process work.
  • Support the Senior System and Business Analyst on assigned tasks and projects.
  • Process a daily quota of change orders to support the business.
  • Process complex change orders accurately and promptly using the electronic documentation system, based on professional concepts and company objectives.
  • Audit documentation changes for accuracy, completeness, and compliance with language, procedural, and regulatory requirements.
  • Ensure changes are closed-loop, with discrepancies addressed before release, applying regulatory and change control principles to analysis of situations or data.
  • Provide verbal and written guidance to internal customers and originators on correcting issues or discrepancies.
  • Respond promptly to questions and issues raised by originators and approvers.
  • Raise issues relevant to the Document Control team and propose detailed solutions and alternatives with justification.
  • Maintain data integrity in Agile form fields and update item forms to accommodate changes in company processes and requirements.
  • Use in-depth Agile system and change control knowledge to troubleshoot issues and determine when to escalate them to IT.
  • Understand how Agile links to internal and external systems and support Agile integration-related requests.
  • Update Document and Change Control procedures as needed.
Desired Qualifications
  • Technical and functional knowledge of PLM systems.
  • Project Management.
  • Medical device experience.

About the company

Intuitive Surgical makes da Vinci robots that let surgeons operate through a few small incisions, and Ion, a robot that reaches deep into the lungs to take tissue samples. In 2000, da Vinci became the first robotic system cleared by the FDA for general laparoscopic surgery, meaning keyhole operations in the abdomen. A surgeon sits at a nearby console and steers robotic arms holding a 3D camera and wristed instruments, which turn hand movements into smaller, steadier motions. Hospitals buy or lease the robots, then keep paying for the instruments used in each operation and for service. Intuitive was founded in 1995 to commercialize robotic surgery research from SRI International and is based in Sunnyvale, California.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Get referred to Intuitive Surgical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand keeps compounding: da Vinci procedures grew 15% and revenue 19%, to $2.89 billion, in the June 2026 quarter.
  • Room to grow: Intuitive listed 748 open roles in October 2026, including 191 in engineering and 312 in Sunnyvale.
  • Repeat sales steady the business: instruments and service made 76% of revenue in the June 2026 quarter.

What critics are saying

  • Stock grants have shrunk: shares fell 27% from January to October 2026, versus 9% for rival Medtronic.
  • Device giants are moving in: the FDA cleared rival robots from Medtronic in December 2025 and J&J in July 2026.
  • Instrument sales face a court fight: in August 2026, an appeals court revived a repair firm's monopoly suit against Intuitive.

What makes Intuitive Surgical unique

  • Hospitals rent more than they buy: 254 of 468 da Vinci systems placed in the June 2026 quarter were leases.
  • It runs without borrowing: Intuitive had no debt and $8.6 billion in cash and investments in June 2026.
  • Its CEO is a 30-year insider: Dave Rosa, CEO since July 2025, joined as employee number nine in 1996.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 1st, 2026
Intuitive Surgical down 30% in 2026, but Wall Street analysts stay bullish

Intuitive Surgical has lost nearly 30% year-to-date in 2026, making it one of healthcare's biggest losers. The stock fell over 40% by late July. Despite this decline, Wall Street remains bullish—24 of 32 analysts surveyed by S&P Global in September rated it a "buy" or "strong buy." The medical device maker faces several challenges. Growth is slowing whilst the stock trades at a forward price-to-earnings multiple over 33. Competition in China remains difficult, and the company now battles healthcare giants Johnson & Johnson, Medtronic, and Stryker in robotic surgical systems. The expiration of Affordable Care Act subsidies and rising GLP-1 drug usage have also impacted procedure volumes. However, the company's Asian revenue still jumped 20% year-over-year in Q2, suggesting these headwinds aren't insurmountable.

Yahoo Finance
Sep 17th, 2026
Intuitive Surgical, IonQ, and Accenture hold billions in net cash for growth

Investors seeking financial stability often look to companies with more cash than debt, as these businesses have greater flexibility for growth investments, buybacks, and dividends. Intuitive Surgical holds $5.22 billion in net cash. The robotic surgery pioneer achieved 20.7% annual revenue growth over the past two years, whilst its earnings per share increased 17.4% annually over five years. IonQ maintains $2.06 billion in net cash, representing 14.1% of its market capitalisation. The quantum computing company posted 181% annual revenue growth over two years and expects 163% growth next year. Accenture has $1.78 billion in net cash. The professional services firm employs approximately 774,000 people across more than 120 countries. Companies with strong balance sheets can navigate uncertain markets whilst pursuing expansion opportunities without the burden of significant debt obligations.

Yahoo Finance
Aug 23rd, 2026
Thermo Fisher vs Intuitive Surgical: which premium healthcare stock justifies valuation?

Thermo Fisher and Intuitive Surgical both delivered strong recent quarters, but their premium valuations rest on different foundations. Thermo Fisher's case depends on recovery in life sciences spending after the pandemic slowdown. The company's Life Sciences Solutions segment saw reported revenue climb 13% year-over-year, with organic revenue up 3%. The Analytical Instruments business returned to growth after nearly two years of weak demand, suggesting laboratory spending is normalising. Intuitive Surgical maintains its premium through business model strength. The company's non-GAAP gross profit margin reached 70.0%, whilst its non-GAAP operating margin expanded 330 basis points year-over-year to 42.1%. Recurring revenue streams constitute roughly 85% of total sales. Intuitive placed 468 da Vinci surgical units in fiscal Q2, marking 18% year-over-year growth, indicating continued hospital investment in robotic surgery platforms.

Yahoo Finance
Aug 19th, 2026
Abbott beats Q2 estimates with 13% sales growth as diagnostics surge 42%, while Intuitive Surgical posts 19% revenue rise

Abbott Laboratories reported strong fiscal Q2 2026 results, with sales rising 13% on a reported basis and 4.8% on a comparable basis, beating estimates and prompting the company to raise its annual profit forecast. The diagnostics segment was particularly strong, growing 42% to $3.09 billion, driven by its cancer diagnostics business following the Exact Sciences acquisition. Intuitive Surgical also exceeded expectations in Q2 2026, with revenue growing 19% to $2.89 billion and adjusted EPS of $2.80, beating forecasts by $0.30. The company placed 468 da Vinci units during the quarter, an 18% year-over-year increase, whilst maintaining a non-GAAP gross margin of 70.0%. The companies present contrasting investment cases: Abbott offers diversified healthcare portfolio resilience, whilst Intuitive Surgical relies on its robotic surgery ecosystem with recurring revenue comprising approximately 85% of total sales.

PR Newswire
Aug 17th, 2026
Intuitive leases 316,000-sq-ft facility in Penang to manufacture surgical instruments, create 1,200 jobs by 2032

Intuitive, the global leader in minimally invasive care and pioneer of robotic-assisted surgery, has signed a lease agreement with Penang Development Corporation for a new manufacturing facility in Malaysia. The 316,000-square-foot site in Bandar Cassia Technology Park will produce surgical instruments and electromechanical devices for Intuitive's da Vinci surgical system. The facility is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032. The investment reflects Intuitive's commitment to Asia Pacific, where its da Vinci systems have treated more than 2.5 million patients across 13 markets over two decades. The expansion aims to support growing demand for robotic-assisted surgery across the region and strengthen Penang's position as a MedTech manufacturing hub in Southeast Asia.